General Information |
|
| NSE Symbol* | BLISSGVS |
| Name of the Company* | BLISS GVS PHARMA LIMITED |
| ISIN* | INE416D01022 |
| Type of Meeting |
1) Board Meeting |
| Details of Committee Meeting or Other Type of Meeting | |
| Type of Intimation* | New |
| Reason for Re-schedule (postpone or prepone) / Cancellation | |
| Proposed Meeting Date | 2026-02-10 |
| Original Meeting Date | |
| Whether trading window is closed* | Yes |
| Trading Window Closure- Start date | 2026-01-01 |
| Details of Trading Window Closure End date | 2026-02-12 |
| Short Notice | |
| Date of Report* | 2026-02-03 |
Agenda Details |
|
| Agenda* |
1) Dividend 2) Financial results |
| Whether results are audited or unaudited | Unaudited |
| Nature of report standalone or consolidated | Standalone And Consolidated |
| Period end Type | Quarterly |
| Period up to (Month) | December |
| Period up to (Year) | 2025 |
| Mode of raising Funds | |
| Type of Dividend |
1) Interim |
| Remarks (website dissemination) | We wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, February 10, 2026, at the registered office of the Company, inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025 and Interim Dividend, if any, for the financial year 2025-2026. |